Search research articles
Contact Us
Filters
Showing results (121-130 of 141) with videos related to
Page
of 15
Sort By:
Genes & Development
|
March 5, 2008
The Ets transcription factor Elf5 specifies mammary alveolar cell fate
Samantha R Oakes, Matthew J Naylor, Marie-Liesse Asselin-Labat, et al.
Radiology
|
December 17, 2015
Findings from Structural MR Imaging in Military Traumatic Brain Injury
Gerard Riedy, Justin S Senseney, Wei Liu, et al.
Plos Genetics
|
January 3, 2020
ELF5 modulates the estrogen receptor cistrome in breast cancer
Catherine L Piggin, Daniel L Roden, Andrew M K Law, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 20, 2011
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Samantha R Oakes, François Vaillant, Elgene Lim, et al.
Brain Imaging and Behavior
|
May 11, 2011
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease
Catherine L Gallagher, Sterling C Johnson, Barbara B Bendlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial
Sebastian Medina, Naoto Tokuyama, Vaishnavi Putcha, et al.
American Journal of Physiology. Renal Physiology
|
July 5, 2018
Void spot assay procedural optimization and software for rapid and objective quantification of rodent voiding function, including overlapping urine spots
Kyle A Wegner, Lisa L Abler, Steven R Oakes, et al.
Oncotarget
|
September 28, 2014
Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease
Heidi N Hilton, Tram B Doan, J Dinny Graham, et al.
Oncogene
|
November 19, 2019
MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma
Lesley Castillo, Adelaide I J Young, Amanda Mawson, et al.
Histopathology
|
May 13, 2010
High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype
Sarah J Zardawi, Ibrahim Zardawi, Catriona M McNeil, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 141) with videos related to
Sort By:
Page
of 15
Genes & Development
|
March 5, 2008
The Ets transcription factor Elf5 specifies mammary alveolar cell fate
Samantha R Oakes, Matthew J Naylor, Marie-Liesse Asselin-Labat, et al.
Radiology
|
December 17, 2015
Findings from Structural MR Imaging in Military Traumatic Brain Injury
Gerard Riedy, Justin S Senseney, Wei Liu, et al.
Plos Genetics
|
January 3, 2020
ELF5 modulates the estrogen receptor cistrome in breast cancer
Catherine L Piggin, Daniel L Roden, Andrew M K Law, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 20, 2011
Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Samantha R Oakes, François Vaillant, Elgene Lim, et al.
Brain Imaging and Behavior
|
May 11, 2011
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease
Catherine L Gallagher, Sterling C Johnson, Barbara B Bendlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2026
AI-Based Pathology classifier Predicts Sensitivity to Enzalutamide in Metastatic Hormone-Sensitive Prostate Cancer: A Biomarker Analysis of the ENZAMET Trial
Sebastian Medina, Naoto Tokuyama, Vaishnavi Putcha, et al.
American Journal of Physiology. Renal Physiology
|
July 5, 2018
Void spot assay procedural optimization and software for rapid and objective quantification of rodent voiding function, including overlapping urine spots
Kyle A Wegner, Lisa L Abler, Steven R Oakes, et al.
Oncotarget
|
September 28, 2014
Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease
Heidi N Hilton, Tram B Doan, J Dinny Graham, et al.
Oncogene
|
November 19, 2019
MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma
Lesley Castillo, Adelaide I J Young, Amanda Mawson, et al.
Histopathology
|
May 13, 2010
High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype
Sarah J Zardawi, Ibrahim Zardawi, Catriona M McNeil, et al.
Page
of 15